• Both improve the immunization process in animals and humans against brucellosis due to inducing IgM and IgG secretion and more protection than pure antigens (OPS and LPS).• LPS-PLGA conjugate vaccine induces more immunogenicity compared to OPS-PLGA nanovaccines. Here, CD40LG is linked to brucellosis.